{"id":"W2047759229","doi":"10.1159/000336892","title":"First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study","year":2012,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"GlaxoSmithKline; Pfizer","keywords":"Bevacizumab; Medicine; Triple-negative breast cancer; Internal medicine; Regimen; Metastatic breast cancer; Oncology; Population; Taxane; Breast cancer; Chemotherapy; Progression-free survival; Surgery; Cancer; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048849,0.0003785969,0.001118672,0.0008350962,0.0002780259,0.0006838955,0.000565009,0.0005207495,0.001220001],"category_scores_gemma":[0.001563796,0.0003805992,0.001500859,0.001078907,0.0002248996,0.00028546,0.0005382256,0.0004668706,0.0002517754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006945189,"about_ca_system_score_gemma":0.000472478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004079903,"about_ca_topic_score_gemma":0.00776122,"domain_scores_codex":[0.9989578,0.0002995848,0.0001302573,0.0002979417,0.0001964896,0.0001179936],"domain_scores_gemma":[0.9990845,0.0002130794,0.0003624278,0.0001101011,0.00006585381,0.0001640403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01238425,0.0004220615,0.9692827,0.0001975237,0.00431982,0.0004666347,0.0002116813,0.0003671169,0.001755711,0.00006161599,0.0008197309,0.00971122],"study_design_scores_gemma":[0.001464777,0.001403022,0.9927863,0.00003916177,0.001756043,0.0005007766,0.0001703911,0.0004596289,0.0002059083,0.00003703051,0.001157512,0.00001944994],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978889,0.001096245,0.00005675705,0.00003138738,0.000007142271,0.00003653515,0.0005521234,0.000003488621,0.0003274645],"genre_scores_gemma":[0.9977645,0.0003298687,0.00009419393,0.00007114533,0.00002274566,0.00004386248,0.00144427,0.00000419732,0.0002252278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004079903,"threshold_uncertainty_score":0.008112311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05396276108214242,"score_gpt":0.407239581350104,"score_spread":0.3532768202679615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}